益佰制药(600594) - 2015 Q1 - 季度财报

Financial Performance - Operating revenue increased by 10.79% to CNY 675,167,821.55 year-on-year[8] - Net profit attributable to shareholders rose by 7.49% to CNY 57,890,593.89 compared to the same period last year[8] - Basic earnings per share increased by 4.29% to CNY 0.146[8] - Total operating revenue for Q1 2015 was CNY 675,167,821.55, an increase of 10.8% compared to CNY 609,420,434.76 in the same period last year[29] - Net profit for Q1 2015 reached CNY 58,964,203.87, representing a 9.1% increase from CNY 54,002,652.31 in the previous year[30] - Earnings per share for Q1 2015 were CNY 0.146, compared to CNY 0.140 in the same quarter last year, indicating a growth of 4.3%[31] - The company reported a total profit of CNY 72,218,243.42 for Q1 2015, up from CNY 65,847,027.32, marking an increase of 6.5%[30] Cash Flow - Cash flow from operating activities decreased significantly by 94.24% to CNY 11,175,110.17[8] - Cash flow from operating activities totaled CNY 793,762,833.96, a decrease of 16.2% from CNY 946,468,901.74 in the previous year[35] - Net cash flow from operating activities was -29,094,772.72 RMB, a decrease from 167,613,101.43 RMB in the previous period[38] - Total cash outflow from operating activities amounted to 564,854,804.19 RMB, compared to 544,395,851.36 RMB in the prior period[38] - Cash inflow from operating activities totaled 535,760,031.47 RMB, down from 712,008,952.79 RMB in the previous period[38] Assets and Liabilities - Total assets decreased by 3.49% to CNY 5,303,787,569.52 compared to the end of the previous year[8] - Current assets decreased from ¥2,706,180,082.24 to ¥2,512,235,560.17, a decline of approximately 7.16%[22] - Total liabilities decreased from ¥2,054,027,270.83 to ¥1,803,175,660.93, a decline of about 12.19%[24] - Total liabilities decreased to CNY 1,428,246,270.53 from CNY 1,639,652,604.47, a reduction of 12.9%[28] - The company's equity attributable to shareholders increased from ¥3,430,250,385.03 to ¥3,488,140,978.92, an increase of about 1.69%[24] Shareholder Information - The total number of shareholders reached 19,756 at the end of the reporting period[12] - The largest shareholder, Dou Qiling, holds 23.15% of the shares, amounting to 91,658,818 shares[13] Other Financial Metrics - Cash flow from operating activities decreased by 94.24% to ¥11,175,110.17, mainly due to reduced sales collections[15] - Non-recurring gains and losses totaled CNY 5,098,996.86 for the period[11] - Government subsidies recognized in the current period amounted to CNY 6,740,318.12[9] - Non-operating income increased by 53.91% to ¥6,778,748.87, driven by an increase in non-recurring gains[15] - Sales expenses for Q1 2015 were CNY 393,794,015.29, compared to CNY 374,524,289.43 in the previous year, an increase of 5.2%[30] - The company recorded an investment loss of CNY 631,434.34 in Q1 2015, compared to a gain of CNY 84,557.87 in the same period last year[30] Investment and Financing Activities - Net cash flow from investing activities was -¥184,660,561.75, a 235.64% increase in outflows due to acquisition payments[15] - Cash inflow from financing activities was 350,000,000.00 RMB, down from 1,188,277,839.26 RMB in the previous period[39] - Net cash flow from financing activities was -10,483,944.43 RMB, a significant decrease from 1,132,855,442.72 RMB in the prior period[39] - Total cash outflow from investment activities was 180,576,530.84 RMB, compared to 54,155,174.37 RMB in the prior period[38] Employee and Stock Information - The company’s employee stock ownership plan has been approved, with subordinate funding already in place[17] - The third unlock period of the stock incentive plan was met, allowing 2,321,400 shares to be listed for trading[16]